Light Therapy System Modulating Brain Waves via Blue Light
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for using stroboscopic light to treat conditions like Alzheimer's and dementia in humans are hindered by side effects such as visual glare, fatigue, and discomfort, and are impractical for extended use due to the need for controlled environments and potential stress induction.
Innovation Solution
A light therapy system that modulates brain activity without affecting vision, using a blue light source operating at 20-50 Hz to stimulate brain waves while minimizing visual discomfort, incorporating a sleep mask or room luminaire with a narrow spectrum stroboscopic blue light source and a broad-spectrum light source to create constant white illumination, ensuring the stroboscopic effect is undetectable.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If stroboscopic light is used to stimulate brain activity for treating Alzheimer's and dementia, then cognitive function and memory are improved, but visual discomfort and side effects increase
Solution Approach 1:
The light source is divided into multiple LEDs emitting at different wavelengths (blue, cyan, green, yellow-green, yellow, orange, red). Each wavelength targets different photoreceptors in the retina, allowing selective stimulation of non-visual pathways while minimizing visual discomfort through spectral distribution
Solution Approach 2:
The system varies the intensity and timing of different wavelength components dynamically. By adjusting the relative intensities of blue vs. other wavelengths and using pulsed patterns at 40Hz, the system optimizes brain wave stimulation while keeping visual perception comfortable through balanced spectral output
2Reliability
If stroboscopic light operates at high intensity to effectively stimulate brain waves, then therapeutic effect is improved, but visual glare and ocular discomfort worsen
Solution Approach 1:
Different regions of the spectrum are assigned different functions: blue light (460nm) provides the 40Hz pulsing stimulus for brain wave entrainment, while other wavelengths (cyan, green, yellow-green, yellow, orange, red) provide continuous illumination to maintain visual comfort and reduce glare perception
Solution Approach 2:
The patent uses intermediate wavelengths (cyan, green, yellow-green, yellow, orange) as mediators between the potentially harmful blue stroboscopic light and the user's visual system. These intermediate wavelengths fill in the spectral gaps during pulsing, reducing the perception of flicker and glare while allowing the blue component to maintain therapeutic intensity
3Duration of action of moving object
If extended exposure to stroboscopic light is required for treatment, then therapeutic effectiveness is improved, but user comfort and practicality worsen
Solution Approach 1:
The system provides continuous multi-wavelength illumination with superimposed 40Hz pulsing on the blue component. This continuous spectral presence maintains visual comfort throughout extended use periods, allowing users to tolerate longer treatment durations without the discomfort that would limit earlier approaches
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system effectively stimulates brain activity for improved cognitive function and memory without the adverse effects of traditional stroboscopic light, making it suitable for prolonged use and improving quality of life for individuals with neurodegenerative conditions.
Implementation Method 1
the eyes contain photoreceptors with high sensitivity for blue light, and these photoreceptors regulate melatonin
Implementation Method 2
exposure to flashing lights that stimulate the brain's immune cells to remove toxic proteins causing the disease. These results were obtained in laboratory studies of rodents (mice) with highly controlled environments, where rodents are exposed to stroboscopic light exposure lasting at least 1 hour. The stroboscopic light typically operated at a frequency of 40 Hz
Implementation Method 3
incorporating a sleep mask or room luminaire with a narrow spectrum stroboscopic blue light source and a broad-spectrum light source to create constant white illumination, ensuring the stroboscopic effect is undetectable
Data Source
AI summary
In certain embodiments a light therapy system (e.g., phototherapy device), such as for treatment of Alzheimer's disease, depression, dementia, short-term memory, or for improved learning, improved athletic performance or improved cognitive performance, is provided where the light system comprises a blue light source that operates at a frequency in the range from 20 to 50 Hz (preferably around 40 Hz), whereby the system enables retinal ganglion cells of a human to be exposed in order to stimulate brain waves (gamma oscillations in the human's brain).